MiR-17~92 suppresses tumor progression in a transgenic mouse model of colorectal cancer.
MiR-17~92 inhibits tumor angiogenesis in CRC mouse model through suppressing expression of several angiogenesis-inducing genes.
High expression of miR-17~92 correlates with reduced angiogenesis in male colorectal cancers in human patients.